Skip to main content
    P

    PACS Group, Inc. (PACS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $47.79
    +2.81 (+6.25%)

    Market Cap: $7.12B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    70%(7/10)
    Avg Surprise
    +12.39%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.59
    Range$0.55 - $0.67
    5 analysts
    EPS Revisions
    2
    0
    7d
    3
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.55+7.6%
    60d ago$0.61-3.6%
    30d ago$0.60-1.6%
    7d ago$0.60-1.6%
    Current$0.59
    Revenue Consensus
    $1.5B
    Range$1.4B - $1.5B
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.95
    Range$0.83 - $1.18
    5 analysts
    Revenue Consensus
    $1.6B
    Range$1.6B - $1.7B
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.95---
    Sep 26EST
    		-$0.59---
    Jun 26
    Reported Aug 4
    		$0.63$0.55+14.55%Beat+40.0%
    Mar 26
    Reported May 11
    		$0.64$0.41+56.10%Beat+52.4%
    Dec 25
    Reported Feb 26
    		$0.43$0.48-10.42%Miss+9.9%
    Sep 25
    Reported Nov 19
    		$0.45$0.47-4.26%Miss+32.4%
    Jun 25
    Reported Aug 18
    		$0.45$0.48-6.25%Miss-6.2%
    Mar 25
    Reported May 19
    		$0.42$0.40+5.00%Beat+23.5%
    Dec 24
    Reported Feb 26
    		$0.39$0.35+11.74%Beat-
    Sep 24
    Reported Nov 8
    		$0.34$0.33+3.03%Beat-
    Jun 24
    Reported Aug 12
    		$0.48$0.35+37.14%Beat-
    Mar 24
    Reported May 13
    		$0.34$0.29+17.24%Beat-

    Key Metrics

    Valuation
    P/E Ratio22.23EV/EBITDA15.83x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin4.85%Operating Margin7.66%
    ROE27.90%ROIC21.37%
    Financial Health
    Debt/Equity0.22xInterest Coverage13.94x
    Current Ratio0.91xQuick Ratio0.91x
    Trading Statistics
    Beta-0.08Avg Volume814.12K
    52-Week High$49.4952-Week Low$10.31

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$44.00
    SMA 20$42.87
    SMA 50$43.66
    SMA 200$39.31
    EMA 10$44.38
    EMA 20$43.65
    EMA 50$43.26
    EMA 200$37.68

    MACD

    Line: 0.61Signal: 0.06Hist: 0.55

    ADX

    ADX: 21.4+DI: 31.6-DI: 9.3

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down60.0
    PSAR$42.43

    Bollinger Bands

    Upper Band$46.13
    Lower Band$39.62
    %B Position1519%(Upper)
    Band Width1.26

    RSI (14-Day)

    Overbought
    71.8

    Momentum Oscillators

    Stoch %K94.4
    Stoch %D91.6
    Williams %R-4.9
    ROC (10d)16.5%
    Momentum6.76
    CCI (20d)253.2
    MFI (14d)77.1

    Volatility Measures

    ATR (14d)$1.58(3.3%)
    StdDev (20d)1.63
    Hist Vol34.7%(Moderate)

    Volume Flow

    VWAP$46.84
    OBV53.0M
    AD Line28.5M
    CMF (20d)0.105

    Volume Metrics

    Avg Vol (20d)803.1K
    Vol Ratio2.1x(High)
    VWMA (20d)$43.08

    Pivot Points

    R3$46.32
    R2$45.66
    R1$45.32
    Pivot Point$44.66
    S1$44.32
    S2$43.66
    S3$43.32

    Advanced Oscillators

    TSI12.97
    Ultimate Osc70.0
    KST12.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.43B$1.42B$1.36B$1.34B$1.31B$1.28B$1.21B$1.03B$935.71M$919.84M$853.20M$789.19M
    Cost of Revenue$1.09B$1.07B$1.04B$1.05B$1.02B$1.02B$949.35M$849.60M$762.15M$735.99M$679.63M$638.49M
    Gross Profit$338.46M$345.96M$319.21M$298.31M$288.36M$253.36M$258.54M$176.71M$173.56M$183.84M$173.56M$150.69M
    Operating Expenses$229.13M$225.92M$224.53M$212.04M$207.86M$205.22M$186.56M$153.74M$210.74M$118.53M$111.03M$114.29M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$114.31M$112.31M$113.49M$102.53M$100.33M$98.72M$89.64M$70.59M$136.67M$46.91M$41.96M$49.56M
    Operating Income$109.33M$120.03M$94.69M$86.27M$80.50M$48.14M$71.98M$22.96M$-37,179,000$65.31M$62.54M$36.40M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$6.04M$6.42M$8.58M$8.53M$4.35M$6.90M$9.30M$9.03M$9.91M$16.10M$13.76M$10.22M
    Income Before Tax$105.84M$113.74M$86.81M$76.30M$78.61M$42.73M$61.20M$33.66M$-50,999,000$57.70M$49.23M$27.39M
    Income Tax Expense$29.49M$33.07M$27.03M$23.97M$27.65M$14.35M$25.01M$17.45M$-19,123,000$22.88M$15.10M$7.47M
    Net Income$76.35M$80.67M$59.78M$52.33M$50.97M$28.38M$36.19M$16.21M$-31,876,000$34.82M$34.14M$19.93M
    EBITDA$132.79M$139.02M$111.55M$99.23M$96.93M$63.13M$84.20M$54.68M$-30,840,000$82.69M$71.51M$44.53M
    EBIT$111.88M$120.16M$95.39M$84.83M$82.97M$49.63M$70.50M$42.69M$-41,084,000$73.80M$62.99M$37.61M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PACS

    PACS Valuation and Fair Value

    P/E
    22.2x
    Forward P/E
    15.5x
    EV/EBITDA
    15.8x
    PEG
    1.0x
    P/B
    6.8x
    See GNG's fair value

    PACS Profitability: Margins, ROIC and FCF

    Gross margin
    23.5%
    Operating margin
    7.7%
    Net margin
    4.9%
    ROIC
    21.4%
    ROE
    27.9%
    FCF margin
    2.2%

    PACS Competitors

    CompanyTicker
    Ionis Pharmaceuticals IncIONS
    Merus BVMRUS
    Spyre Therapeutics Inc.SYRE
    Praxis Precision Medicines IncPRAX
    HealthEquity IncHQY
    Amneal Pharmaceuticals, Inc. Class A Common StockAMRX
    AptarGroup IncATR
    Lantheus Holdings IncLNTH

    Sector: Healthcare

    PACS Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    2
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0

    PACS Bull Case vs Bear Case

    Bull case

    • PACS earns a 21.4% return on invested capital.
    • 100.0% of PACS's analyst ratings are Buy or Strong Buy.

    PACS Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    8.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.59
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    3 up, 0 down

    Frequently Asked Questions About PACS

    Does PACS pay dividends?

    PACS Group, Inc. (PACS) does not currently pay a regular dividend.

    What is PACS's P/E ratio?

    PACS Group, Inc. has a price-to-earnings (P/E) ratio of 22.23.

    What is PACS's market cap?

    PACS Group, Inc. (PACS) has a market capitalization of $7.12B with a current stock price of $47.79.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In